Anti-Rheumatics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027
The global anti-rheumatics market reached a value of US$ 61.1 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 72.1 Billion by 2027, exhibiting at a CAGR of 2.74% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Anti-rheumatics refers to drugs used to treat different symptoms of rheumatoid arthritis. These drugs are also utilized for treating inflammatory myositis and bowel diseases, various types of cancers, and connective tissue diseases, such as systemic sclerosis (SSc), systematic lupus erythematosus (SLE), and Sjogren syndrome (SS). They can be administered orally, subcutaneously (SC) or intravenously (IV) into the body. They assist in decreasing inflammation, preventing joint damage, reducing pain and swelling, and slowing the progression of arthritis. As a result, anti-rheumatics are increasingly being prescribed by specialists like rheumatologists, gastroenterologists or dermatologists across the globe.
Anti-Rheumatics Market Trends:
Rheumatoid arthritis is an inflammatory disease that causes swelling and pain in joints. It can also damage the skin, eyes, lungs, heart, and blood vessels. Therefore, the increasing prevalence of this medical condition represents one of the primary factors catalyzing the demand for anti-rheumatics around the world. These drugs aid in preventing bone deformity and improving overall body functions. As a result, their demand is escalating among the geriatric population, which is relatively more prone to these diseases. Furthermore, the growing development in the field of biosimilars and novel biologic therapies are creating a favorable market outlook. These therapies target individual molecules and act faster compared to conventional drugs. They are usually provided in combination with the disease-modifying anti-rheumatic drug (DMARD) to patients who have not responded to other treatments. The market is also influenced by the rising awareness among the masses about the easy availability of anti-rheumatics worldwide. Other significant factors, including a considerable rise in healthcare expenditure and extensive growth in the life sciences industry, are projected to drive the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global anti-rheumatics market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on type, drug class, route of drug administration and distribution channel.
Breakup by Type:
Prescription-based Drugs
Over-the-Counter Drugs
Breakup by Drug Class:
Disease Modifying Anti-Rheumatics Drugs (DMARD's)
Nonsteroidal Anti-Inflammatory Drugs (NSAID's)
Corticosteroids
Uric Acid Drugs
Others
Breakup by Route of Drug Administration:
Oral
Parenteral
Others
Breakup by Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
E-Commerce
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Amgen Inc., AstraZeneca plc, Biogen Inc., Bristol-Myers Squibb Company, Celltrion Inc., Eli Lilly and Company, F. Hoffmann-La Roche AG, Johnson & Johnsons, Pfizer Inc. and Sanofi SA.
Key Questions Answered in This Report:
How has the global anti-rheumatics market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global anti-rheumatics market?
What are the key regional markets?
What is the breakup of the market based on the type?
What is the breakup of the market based on the drug class?
What is the breakup of the market based on the route of drug administration?
What is the breakup of the market based on the distribution channel?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global anti-rheumatics market and who are the key players?
What is the degree of competition in the industry?
Anti-rheumatics refers to drugs used to treat different symptoms of rheumatoid arthritis. These drugs are also utilized for treating inflammatory myositis and bowel diseases, various types of cancers, and connective tissue diseases, such as systemic sclerosis (SSc), systematic lupus erythematosus (SLE), and Sjogren syndrome (SS). They can be administered orally, subcutaneously (SC) or intravenously (IV) into the body. They assist in decreasing inflammation, preventing joint damage, reducing pain and swelling, and slowing the progression of arthritis. As a result, anti-rheumatics are increasingly being prescribed by specialists like rheumatologists, gastroenterologists or dermatologists across the globe.
Anti-Rheumatics Market Trends:
Rheumatoid arthritis is an inflammatory disease that causes swelling and pain in joints. It can also damage the skin, eyes, lungs, heart, and blood vessels. Therefore, the increasing prevalence of this medical condition represents one of the primary factors catalyzing the demand for anti-rheumatics around the world. These drugs aid in preventing bone deformity and improving overall body functions. As a result, their demand is escalating among the geriatric population, which is relatively more prone to these diseases. Furthermore, the growing development in the field of biosimilars and novel biologic therapies are creating a favorable market outlook. These therapies target individual molecules and act faster compared to conventional drugs. They are usually provided in combination with the disease-modifying anti-rheumatic drug (DMARD) to patients who have not responded to other treatments. The market is also influenced by the rising awareness among the masses about the easy availability of anti-rheumatics worldwide. Other significant factors, including a considerable rise in healthcare expenditure and extensive growth in the life sciences industry, are projected to drive the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global anti-rheumatics market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on type, drug class, route of drug administration and distribution channel.
Breakup by Type:
Prescription-based Drugs
Over-the-Counter Drugs
Breakup by Drug Class:
Disease Modifying Anti-Rheumatics Drugs (DMARD's)
Nonsteroidal Anti-Inflammatory Drugs (NSAID's)
Corticosteroids
Uric Acid Drugs
Others
Breakup by Route of Drug Administration:
Oral
Parenteral
Others
Breakup by Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
E-Commerce
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Amgen Inc., AstraZeneca plc, Biogen Inc., Bristol-Myers Squibb Company, Celltrion Inc., Eli Lilly and Company, F. Hoffmann-La Roche AG, Johnson & Johnsons, Pfizer Inc. and Sanofi SA.
Key Questions Answered in This Report:
How has the global anti-rheumatics market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global anti-rheumatics market?
What are the key regional markets?
What is the breakup of the market based on the type?
What is the breakup of the market based on the drug class?
What is the breakup of the market based on the route of drug administration?
What is the breakup of the market based on the distribution channel?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global anti-rheumatics market and who are the key players?
What is the degree of competition in the industry?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL ANTI-RHEUMATICS MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY TYPE
6.1 Prescription-based Drugs
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Over-the-Counter Drugs
6.2.1 Market Trends
6.2.2 Market Forecast
7 MARKET BREAKUP BY DRUG CLASS
7.1 Disease Modifying Anti-Rheumatics Drugs (DMARD's)
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Nonsteroidal Anti-Inflammatory Drugs (NSAID's)
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Corticosteroids
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Uric Acid Drugs
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 MARKET BREAKUP BY ROUTE OF DRUG ADMINISTRATION
8.1 Oral
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Parenteral
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 MARKET BREAKUP BY DISTRIBUTION CHANNEL
9.1 Hospital Pharmacies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Retail Pharmacies
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 E-Commerce
9.3.1 Market Trends
9.3.2 Market Forecast
10 MARKET BREAKUP BY REGION
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT ANALYSIS
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 VALUE CHAIN ANALYSIS
13 PORTERS FIVE FORCES ANALYSIS
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 PRICE ANALYSIS
15 COMPETITIVE LANDSCAPE
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 AbbVie Inc.
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Amgen Inc.
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 AstraZeneca plc
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 Biogen Inc.
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 Bristol-Myers Squibb Company
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 Celltrion Inc.
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 Eli Lilly and Company
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 F. Hoffmann-La Roche AG
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.9 Johnson & Johnsons
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Pfizer Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11 Sanofi SA
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL ANTI-RHEUMATICS MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY TYPE
6.1 Prescription-based Drugs
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Over-the-Counter Drugs
6.2.1 Market Trends
6.2.2 Market Forecast
7 MARKET BREAKUP BY DRUG CLASS
7.1 Disease Modifying Anti-Rheumatics Drugs (DMARD's)
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Nonsteroidal Anti-Inflammatory Drugs (NSAID's)
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Corticosteroids
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Uric Acid Drugs
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 MARKET BREAKUP BY ROUTE OF DRUG ADMINISTRATION
8.1 Oral
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Parenteral
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 MARKET BREAKUP BY DISTRIBUTION CHANNEL
9.1 Hospital Pharmacies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Retail Pharmacies
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 E-Commerce
9.3.1 Market Trends
9.3.2 Market Forecast
10 MARKET BREAKUP BY REGION
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT ANALYSIS
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 VALUE CHAIN ANALYSIS
13 PORTERS FIVE FORCES ANALYSIS
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 PRICE ANALYSIS
15 COMPETITIVE LANDSCAPE
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 AbbVie Inc.
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Amgen Inc.
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 AstraZeneca plc
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 Biogen Inc.
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 Bristol-Myers Squibb Company
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 Celltrion Inc.
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 Eli Lilly and Company
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 F. Hoffmann-La Roche AG
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.9 Johnson & Johnsons
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Pfizer Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11 Sanofi SA
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis
LIST OF TABLES
Table 1: Global: Anti-Rheumatics Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Anti-Rheumatics Market Forecast: Breakup by Type (in Million US$), 2022-2027
Table 3: Global: Anti-Rheumatics Market Forecast: Breakup by Drug Class (in Million US$), 2022-2027
Table 4: Global: Anti-Rheumatics Market Forecast: Breakup by Route of Drug Administration (in Million US$), 2022-2027
Table 5: Global: Anti-Rheumatics Market Forecast: Breakup by Distribution Channel (in Million US$), 2022-2027
Table 6: Global: Anti-Rheumatics Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 7: Global: Anti-Rheumatics Market: Competitive Structure
Table 8: Global: Anti-Rheumatics Market: Key Players
Table 1: Global: Anti-Rheumatics Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Anti-Rheumatics Market Forecast: Breakup by Type (in Million US$), 2022-2027
Table 3: Global: Anti-Rheumatics Market Forecast: Breakup by Drug Class (in Million US$), 2022-2027
Table 4: Global: Anti-Rheumatics Market Forecast: Breakup by Route of Drug Administration (in Million US$), 2022-2027
Table 5: Global: Anti-Rheumatics Market Forecast: Breakup by Distribution Channel (in Million US$), 2022-2027
Table 6: Global: Anti-Rheumatics Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 7: Global: Anti-Rheumatics Market: Competitive Structure
Table 8: Global: Anti-Rheumatics Market: Key Players
LIST OF FIGURES
Figure 1: Global: Anti-Rheumatics Market: Major Drivers and Challenges
Figure 2: Global: Anti-Rheumatics Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Anti-Rheumatics Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Anti-Rheumatics Market: Breakup by Type (in %), 2021
Figure 5: Global: Anti-Rheumatics Market: Breakup by Drug Class (in %), 2021
Figure 6: Global: Anti-Rheumatics Market: Breakup by Route of Drug Administration (in %), 2021
Figure 7: Global: Anti-Rheumatics Market: Breakup by Distribution Channel (in %), 2021
Figure 8: Global: Anti-Rheumatics Market: Breakup by Region (in %), 2021
Figure 9: Global: Anti-Rheumatics (Prescription-based Drugs) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Anti-Rheumatics (Prescription-based Drugs) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Anti-Rheumatics (Over-the-Counter Drugs) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Anti-Rheumatics (Over-the-Counter Drugs) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Anti-Rheumatics (Disease Modifying Anti-Rheumatics Drugs (DMARD's)) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Anti-Rheumatics (Disease Modifying Anti-Rheumatics Drugs (DMARD's)) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Anti-Rheumatics (Nonsteroidal Anti-Inflammatory Drugs (NSAID's)) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Anti-Rheumatics (Nonsteroidal Anti-Inflammatory Drugs (NSAID's)) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Anti-Rheumatics (Corticosteroids) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Anti-Rheumatics (Corticosteroids) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Anti-Rheumatics (Uric Acid Drugs) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Anti-Rheumatics (Uric Acid Drugs) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Anti-Rheumatics (Other Drug Classes) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Anti-Rheumatics (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Anti-Rheumatics (Oral) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Anti-Rheumatics (Oral) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Anti-Rheumatics (Parenteral) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Anti-Rheumatics (Parenteral) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Anti-Rheumatics (Other Routes of Drug Administration) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Anti-Rheumatics (Other Routes of Drug Administration) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: Anti-Rheumatics (Hospital Pharmacies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: Anti-Rheumatics (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Global: Anti-Rheumatics (Retail Pharmacies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Global: Anti-Rheumatics (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Global: Anti-Rheumatics (E-Commerce) Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Global: Anti-Rheumatics (E-Commerce) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: North America: Anti-Rheumatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: North America: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: United States: Anti-Rheumatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: United States: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: Canada: Anti-Rheumatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: Canada: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: Asia-Pacific: Anti-Rheumatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: Asia-Pacific: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: China: Anti-Rheumatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: China: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: Japan: Anti-Rheumatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: Japan: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: India: Anti-Rheumatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: India: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: South Korea: Anti-Rheumatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: South Korea: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: Australia: Anti-Rheumatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: Australia: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: Indonesia: Anti-Rheumatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: Indonesia: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: Others: Anti-Rheumatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: Others: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: Europe: Anti-Rheumatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: Europe: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Germany: Anti-Rheumatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Germany: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: France: Anti-Rheumatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: France: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: United Kingdom: Anti-Rheumatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: United Kingdom: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Italy: Anti-Rheumatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Italy: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: Spain: Anti-Rheumatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: Spain: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: Russia: Anti-Rheumatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: Russia: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Others: Anti-Rheumatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: Others: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Latin America: Anti-Rheumatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: Latin America: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Brazil: Anti-Rheumatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: Brazil: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Mexico: Anti-Rheumatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 78: Mexico: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Others: Anti-Rheumatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 80: Others: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 81: Middle East and Africa: Anti-Rheumatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 82: Middle East and Africa: Anti-Rheumatics Market: Breakup by Country (in %), 2021
Figure 83: Middle East and Africa: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 84: Global: Anti-Rheumatics Industry: SWOT Analysis
Figure 85: Global: Anti-Rheumatics Industry: Value Chain Analysis
Figure 86: Global: Anti-Rheumatics Industry: Porter's Five Forces Analysis
Figure 1: Global: Anti-Rheumatics Market: Major Drivers and Challenges
Figure 2: Global: Anti-Rheumatics Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Anti-Rheumatics Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Anti-Rheumatics Market: Breakup by Type (in %), 2021
Figure 5: Global: Anti-Rheumatics Market: Breakup by Drug Class (in %), 2021
Figure 6: Global: Anti-Rheumatics Market: Breakup by Route of Drug Administration (in %), 2021
Figure 7: Global: Anti-Rheumatics Market: Breakup by Distribution Channel (in %), 2021
Figure 8: Global: Anti-Rheumatics Market: Breakup by Region (in %), 2021
Figure 9: Global: Anti-Rheumatics (Prescription-based Drugs) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Anti-Rheumatics (Prescription-based Drugs) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Anti-Rheumatics (Over-the-Counter Drugs) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Anti-Rheumatics (Over-the-Counter Drugs) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Anti-Rheumatics (Disease Modifying Anti-Rheumatics Drugs (DMARD's)) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Anti-Rheumatics (Disease Modifying Anti-Rheumatics Drugs (DMARD's)) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Anti-Rheumatics (Nonsteroidal Anti-Inflammatory Drugs (NSAID's)) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Anti-Rheumatics (Nonsteroidal Anti-Inflammatory Drugs (NSAID's)) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Anti-Rheumatics (Corticosteroids) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Anti-Rheumatics (Corticosteroids) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Anti-Rheumatics (Uric Acid Drugs) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Anti-Rheumatics (Uric Acid Drugs) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Anti-Rheumatics (Other Drug Classes) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Anti-Rheumatics (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Anti-Rheumatics (Oral) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Anti-Rheumatics (Oral) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Anti-Rheumatics (Parenteral) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Anti-Rheumatics (Parenteral) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Anti-Rheumatics (Other Routes of Drug Administration) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Anti-Rheumatics (Other Routes of Drug Administration) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: Anti-Rheumatics (Hospital Pharmacies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: Anti-Rheumatics (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Global: Anti-Rheumatics (Retail Pharmacies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Global: Anti-Rheumatics (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Global: Anti-Rheumatics (E-Commerce) Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Global: Anti-Rheumatics (E-Commerce) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: North America: Anti-Rheumatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: North America: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: United States: Anti-Rheumatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: United States: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: Canada: Anti-Rheumatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: Canada: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: Asia-Pacific: Anti-Rheumatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: Asia-Pacific: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: China: Anti-Rheumatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: China: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: Japan: Anti-Rheumatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: Japan: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: India: Anti-Rheumatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: India: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: South Korea: Anti-Rheumatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: South Korea: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: Australia: Anti-Rheumatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: Australia: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: Indonesia: Anti-Rheumatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: Indonesia: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: Others: Anti-Rheumatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: Others: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: Europe: Anti-Rheumatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: Europe: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Germany: Anti-Rheumatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Germany: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: France: Anti-Rheumatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: France: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: United Kingdom: Anti-Rheumatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: United Kingdom: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Italy: Anti-Rheumatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Italy: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: Spain: Anti-Rheumatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: Spain: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: Russia: Anti-Rheumatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: Russia: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Others: Anti-Rheumatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: Others: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Latin America: Anti-Rheumatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: Latin America: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Brazil: Anti-Rheumatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: Brazil: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Mexico: Anti-Rheumatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 78: Mexico: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Others: Anti-Rheumatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 80: Others: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 81: Middle East and Africa: Anti-Rheumatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 82: Middle East and Africa: Anti-Rheumatics Market: Breakup by Country (in %), 2021
Figure 83: Middle East and Africa: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 84: Global: Anti-Rheumatics Industry: SWOT Analysis
Figure 85: Global: Anti-Rheumatics Industry: Value Chain Analysis
Figure 86: Global: Anti-Rheumatics Industry: Porter's Five Forces Analysis
